Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
International Journal of Molecular Medicine
|
October 20, 2004
Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation
Ofer Merimsky
Oncology Letters
|
February 20, 2013
The evolution in melanoma treatment as a reflection of precision-oriented medicine
Igal Kushnir, Ofer Merimsky
Molecular and Clinical Oncology
|
September 15, 2018
Efficacy and safety of Nivolumab in non-small cell lung cancer patients in Tel-Aviv tertiary medical center: Facing the reality
Sivan Shamai, Ofer Merimsky
The Israel Medical Association Journal : IMAJ
|
June 4, 2002
Bone metastases of renal cell carcinoma: the role of surgery
Jacob Bickels, Ofer Merimsky
The Israel Medical Association Journal : IMAJ
|
October 17, 2018
Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective
Sivan Shamai, Ofer Merimsky
Frontiers in Oncology
|
July 12, 2017
Soft-Tissue Sarcoma following Traumatic Injury: Case Report and Review of the Literature
Yael Bar, Ofer Merimsky
Expert Review of Anticancer Therapy
|
March 12, 2014
Optimal management of sarcomas of the breast: an update
Eran Nizri, Ofer Merimsky, Guy Lahat
The Israel Medical Association Journal : IMAJ
|
February 13, 2018
A Case Report of Metastatic Primary Thyroid Leiomyosarcoma Treated with Pazopanib
Igal Kushnir, Viacheslav Soyfer, Ofer Merimsky
International Journal of Oncology
|
June 6, 2007
Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model
Ofer Merimsky, Yaara Gorzalczany, Ronit Sagi-Eisenberg
Translational Oncology
|
September 8, 2019
Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent Mechanism
Yaara Gorzalczany, Ofer Merimsky, Ronit Sagi-Eisenberg
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
International Journal of Molecular Medicine
|
October 20, 2004
Targeting metastatic leiomyosarcoma by rapamycin plus gemcitabine: an intriguing clinical observation
Ofer Merimsky
Oncology Letters
|
February 20, 2013
The evolution in melanoma treatment as a reflection of precision-oriented medicine
Igal Kushnir, Ofer Merimsky
Molecular and Clinical Oncology
|
September 15, 2018
Efficacy and safety of Nivolumab in non-small cell lung cancer patients in Tel-Aviv tertiary medical center: Facing the reality
Sivan Shamai, Ofer Merimsky
The Israel Medical Association Journal : IMAJ
|
June 4, 2002
Bone metastases of renal cell carcinoma: the role of surgery
Jacob Bickels, Ofer Merimsky
The Israel Medical Association Journal : IMAJ
|
October 17, 2018
Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective
Sivan Shamai, Ofer Merimsky
Frontiers in Oncology
|
July 12, 2017
Soft-Tissue Sarcoma following Traumatic Injury: Case Report and Review of the Literature
Yael Bar, Ofer Merimsky
Expert Review of Anticancer Therapy
|
March 12, 2014
Optimal management of sarcomas of the breast: an update
Eran Nizri, Ofer Merimsky, Guy Lahat
The Israel Medical Association Journal : IMAJ
|
February 13, 2018
A Case Report of Metastatic Primary Thyroid Leiomyosarcoma Treated with Pazopanib
Igal Kushnir, Viacheslav Soyfer, Ofer Merimsky
International Journal of Oncology
|
June 6, 2007
Molecular impacts of rapamycin-based drug combinations: combining rapamycin with gemcitabine or imatinib mesylate (Gleevec) in a human leiomyosarcoma model
Ofer Merimsky, Yaara Gorzalczany, Ronit Sagi-Eisenberg
Translational Oncology
|
September 8, 2019
Mast Cells Are Directly Activated by Cancer Cell-Derived Extracellular Vesicles by a CD73- and Adenosine-Dependent Mechanism
Yaara Gorzalczany, Ofer Merimsky, Ronit Sagi-Eisenberg
Page
of 8